First Niagara Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$308K Sell
2,631
-103
-4% -$11.7K 0.09% 150
2016
Q1
$283K Hold
2,734
0.08% 156
2015
Q4
$272K Hold
2,734
0.08% 158
2015
Q3
$250K Sell
2,734
-16
-0.6% -$1.6K 0.07% 188
2015
Q2
$292K Buy
2,750
+16
+0.6% +$1.77K 0.07% 190
2015
Q1
$312K Sell
2,734
-105
-4% -$12K 0.07% 178
2014
Q4
$312K Sell
2,839
-767
-21% -$80.9K 0.07% 180
2014
Q3
$352K Sell
3,606
-103
-3% -$10.1K 0.07% 167
2014
Q2
$374K Hold
3,709
0.08% 164
2014
Q1
$340K Sell
3,709
-965
-21% -$88.9K 0.07% 176
2013
Q4
$423K Hold
4,674
0.08% 167
2013
Q3
$373K Hold
4,674
0.08% 172
2013
Q2
$340K Buy
+4,674
New +$349K 0.07% 180

Other funds holding ZBH

First Niagara Bank's ZBH Position: Q2 2016 in Review

First Niagara Bank reduced its Zimmer Biomet (ZBH) stake by 3.8% in Q2 2016, selling an estimated $11.7K and leaving 2,631 shares worth $308K. The position accounts for 0.09% of the portfolio, ranked #150.

First Niagara Bank first reported a position in ZBH in Q2 2013 and has held it in 13 quarters since. The position peaked at $423K in Q4 2013. 766 funds tracked by Wall St. Rank hold ZBH as of Q2 2016.

  • First Niagara Bank held 2,631 shares of Zimmer Biomet worth $308K as of Q2 2016.
  • First Niagara Bank sold 103 Zimmer Biomet shares in Q2 2016, an estimated $11.7K.
  • Zimmer Biomet made up 0.09% of First Niagara Bank's portfolio in Q2 2016, its #150 holding.
  • First Niagara Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Zimmer Biomet position peaked at $423K in Q4 2013.
  • 766 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.